Alibaba Health Plunges After China Halts Drug Coding System
This article is for subscribers only.
Alibaba Health Information Technology Ltd. plunged after China said it will halt the implementation of a drug-coding system that’s developed and operated by the company.
Alibaba Health shares fell 14 percent to HK$4.14 in Hong Kong trading. The China Food & Drug Administration suspended the electronic coding system that identifies counterfeit medicines as it made draft amendments to existing rules, allowing the use of other methods of tracking medicines back to their origin, the administration said in a statement Saturday.